These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 6126110)
1. The prevalence of persistent abnormal involuntary movements among patients in a Nigerian long stay psychiatric unit. Odejide AO Afr J Med Med Sci; 1981; 10(1-2):39-43. PubMed ID: 6126110 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of persistent abnormal involuntary movements among patients in a Nigerian long-stay psychiatric unit. Odejide AO Int Pharmacopsychiatry; 1980; 15(5):292-300. PubMed ID: 6114935 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of tardive dyskinesia. Woerner MG; Kane JM; Lieberman JA; Alvir J; Bergmann KJ; Borenstein M; Schooler NR; Mukherjee S; Rotrosen J; Rubinstein M J Clin Psychopharmacol; 1991 Feb; 11(1):34-42. PubMed ID: 1674949 [TBL] [Abstract][Full Text] [Related]
8. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to "tardive" dyskinesia independent of extent of neuroleptic medication. Reddi K Ir Med J; 1985 Sep; 78(9):270. PubMed ID: 2865231 [No Abstract] [Full Text] [Related]
9. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. Silver H; Geraisy N; Schwartz M J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856 [TBL] [Abstract][Full Text] [Related]
10. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication. Waddington JL; Youssef HA Ir Med J; 1985 May; 78(5):143-6. PubMed ID: 2861172 [No Abstract] [Full Text] [Related]
11. The prevalence of akathisia in patients receiving stable doses of clozapine. Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271 [TBL] [Abstract][Full Text] [Related]
16. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? Crow TJ; Cross AJ; Johnstone EC; Owen F; Owens DG; Waddington JL J Clin Psychopharmacol; 1982 Oct; 2(5):336-40. PubMed ID: 7130435 [TBL] [Abstract][Full Text] [Related]
17. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223 [TBL] [Abstract][Full Text] [Related]
18. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients. Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765 [TBL] [Abstract][Full Text] [Related]
19. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
20. Movement disorders in patients treated with long-acting injectable antipsychotic drugs. Bransgrove LL; Kelly MW Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]